Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy [Phase 3]
Phase 3 study evaluating adjuvant cemiplimab therapy in patients with surgically removed non-small cell lung cancer who have not received pr…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) [Phase 3]
Nuvation Bio is conducting a Phase 3 trial (TRUST-IV) of taletrectinib vs placebo as adjuvant therapy in ROS1-positive non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Pharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms [Phase 2, Phase 3]
A pharmacogenomics study evaluating how single nucleotide polymorphisms may influence Alectinib treatment in non-small cell lung cancer, con…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating cilengitide in combination with radiochemotherapy for locally advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
A completed clinical trial update reporting the real-world outcomes of first-line nivolumab plus ipilimumab with chemotherapy for non-small …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease [Phase 3]
Phase 3 trial update on adding hypofractionated high-dose radiation for oligometastatic disease in non-small cell lung cancer; the study is …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC [Phase 3]
A Phase 3 clinical trial is assessing SHR-A2009 in combination with Aumolertinib versus Aumolertinib alone as first-line therapy for EGFR-mu…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) [Phase 1, Phase 2]
Bayer's BAY2927088 is being investigated in a first-in-human Phase 1/2 study for adults with advanced non-small cell lung cancer harboring E…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Harvesting Cells for Experimental Cancer Treatments
An NCI-sponsored clinical trial update indicates enrollment by invitation for a cell-harvesting approach in experimental cancer therapies ac…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]
This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are clo…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure [Phase 2]
A Phase II clinical trial is evaluating microwave ablation combined with tislelizumab and docetaxel for advanced non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change [Phase 2]
A Phase 2 study is evaluating osimertinib for non-small cell lung cancer with EGFR exon 20 alterations; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
A completed post-marketing surveillance study in Japan evaluating durvalumab for non-small cell lung cancer under the Imfinzi/Imjudo brands.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of ZW251 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update notes a study of ZW251 in participants with advanced solid tumors, including hepatocellular carcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II clinical trial evaluating trilaciclib in combination with sacituzumab govitecan for EGFR-mutated advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of Outcomes of Radiofrequency Ablation of Lung Tumors
This clinical trial update notes that the study on outcomes of radiofrequency ablation for lung tumors has been suspended.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation [Phase 1, Phase 2]
Novartis is conducting a platform study of JDQ443 in combination regimens for KRAS G12C-mutant solid tumors, including non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
A clinical trial update indicates ongoing recruitment for a study evaluating cardiopulmonary exercise testing in lung cancer patients before…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating JNJ-90301900 in combination with chemoradiation followed by consolidation immunotherapy for non-small ce…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]
This clinical trial entry describes a Phase 1 study evaluating BNT116 as a single agent and in combination regimens for advanced non-small c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial comparing Telisotuzumab vedotin versus docetaxel in adults with previously treated non-squamous non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is evaluating whether radiotherapy can block oligoprogression in metastatic non-small cell lung cancer. The study i…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
A Shanghai Chest Hospital study is evaluating neoadjuvant chemoimmunotherapy followed by robotic pulmonary resection for stage IIB–III non-s…